Category: Generics Drugs
North America Generics Drugs
-
Antiviral Drugs Market, By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, and Others), By Type (Branded and Generics), By Application (HIV, Hepatitis, Herpes, Influenza, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... been witnessing steady growth over the past few years. Antiviral drugs, also known as antiviral agents or anti-infective medications, are a class of medication used specifically for treating infections caused by viruses. They work by ... Read More
-
Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033
... The growing number of hospitals and clinics, favorable government initiatives, and the rising prevalence of chronic diseases represent some of the key factors driving the market. Generic drugs are medications created to be the same ... Read More
-
Generic Drugs
... CAGR of 6.5% over the analysis period 2024-2030. Small-Molecule Generics, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$538.8 Billion by the end of the analysis ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325412
... Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325412 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, Generics and Drug ... Read More
-
U.S. Pharmaceutical Packaging Services Market Size, Share & Trends Analysis Report By Product (Branded, Generic, Biosimilar, Vaccine, Cell Therapy, Gene Therapy), By Service Line, By Manufacturer Size, And Segment Forecasts, 2025 - 2030
... 2025 to 2030, according to a new report by Grand View Research, Inc. The U.S. pharmaceutical industry is heavily regulated by agencies such as the Food and Drug Administration (FDA), which mandates strict packaging guidelines ... Read More
-
Pharmaceuticals: United States
... of: compounded and biological. Compounded pharmaceutical demand is also segmented by therapeutic class as follows: hormones and related, central nervous system, anti-infective, cardiovascular, nutritional, respiratory, dermatological, and digestive and genito-urinary. To illustrate historical trends, total ... Read More
-
Pharmaceutical Glass Packaging Market Research Report Information by Product Type (Vials, Bottles & Jars, Cartridges & Syringes, Ampoules), by Material Type (Type I, Type II, Type III), by Application (Generic Drugs, Branded Drugs, Biological Drugs), and by Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America) Market Industry Forecast Till 2032
... and by Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America) Market Industry Forecast Till 2032 In 2023, the pharmaceutical glass packaging market was estimated to be worth USD 21,354.2 million. According ... Read More
-
Generics North America (NAFTA) Industry Guide 2019-2028
... descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North ... Read More
-
Generics in Mexico
... the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that ... Read More
-
Generics in North America
... players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now ... Read More
-
Generics in Canada
... key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both ... Read More
-
Generics in the United States
... also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly ... Read More
-
Fill Finish Pharmaceutical Contract Manufacturing Market by Type of Fill Finish Service Offered (Aseptic Filling, Blow-Fill-Seal and Terminal Sterilization), Type of FDF (Generic FDF and Originator FDF), API Potency (Low Potent API and High Potent API), Type of Primary Packaging Container (Ampoules, Cartridges, Prefilled Syringe, Vials and Other Containers), Scale of Operation (Clinical and Commercial), Company Size (Small and Mid-sized Companies, Large / Very Large Companies) and Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World) and Leading Players: Industry Trends and Global Forecasts, Till 2035
... API), Type of Primary Packaging Container (Ampoules, Cartridges, Prefilled Syringe, Vials and Other Containers), Scale of Operation (Clinical and Commercial), Company Size (Small and Mid-sized Companies, Large / Very Large Companies) and Geographical Regions (North ... Read More
-
Pharmaceutical Contract Manufacturing Market by Type of Product Manufactured (API & Intermediates and FDF), Type of API (Originator API and Generic API), API Potency (Low Potent API and High Potent API), Type of FDF (Originator FDF and Generic FDF), Dosage Form (Oral Solids, Liquids, Emulsions and Other Dosage Forms), Type of Packaging Offered (Bottles, Blister, Parenteral and Others), Scale of Operation (Clinical and Commercial), End Users (Small, Mid-sized, and Large and Very Large Companies) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa): Industry Trends and Global Forecasts, Till 2035
... FDF and Generic FDF), Dosage Form (Oral Solids, Liquids, Emulsions and Other Dosage Forms), Type of Packaging Offered (Bottles, Blister, Parenteral and Others), Scale of Operation (Clinical and Commercial), End Users (Small, Mid-sized, and Large ... Read More
-
Generic Pharmaceutical Manufacturing in Canada - Industry Market Research Report
... dispensed by volume. According to 2021 data from the Patented Medicine Prices Review Board (latest data available), average generic drug prices in Canada have declined more than 50.0% over the past decade. To cut healthcare ... Read More
-
2024 North America Inhalation And Nasal Sprays Generic Drugs Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... category is within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates ... Read More
-
2024 United States Inhalation And Nasal Sprays Generic Drugs Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... category is within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates ... Read More
-
Generic Pharmaceutical Manufacturing in the US - Industry Market Research Report
... depends on patent expirations, FDA approvals of new drug applications and competition from foreign companies. Over the past five years, revenue has grown at a CAGR of 0.9% to $53.8 billion, which includes a 14.2% ... Read More
-
United States Generic Drugs Market: Market Size, Forecast, Insights, and Competitive Landscape
... generic drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the United States generic drugs market by segmenting ... Read More
-
United States Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F
... Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F United States generic drugs market is projected to witness a CAGR of 6.68% during the forecast period 2024-2031, growing ... Read More
-
Plunkett's Biotech, Pharmaceuticals & Genetics Industry Almanac 2025: Biotech, Pharmaceuticals & Genetics Industry Market Research, Statistics, Trends and Leading Companies
... vital insights that can help shape strategy for business development, product development and investments. Key Features: Business trends analysis In-depth industry overview Technology trends analysis Forecasts Spending, investment, and consumption discussions In-depth industry statistics and ... Read More
-
Generic Drugs Market Research Report Information by Type (Simple Generics and Super Generics), by Brand (Pure Generic and Branded Generic), by Indication (Central Nervous System (CNS), Cardiovascular, Urology, Oncology, Respiratory, and Others), by Route of Administration (Oral, Topical, Parenteral, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Europe, Asia-Pacific, and Rest of the World – Industry Forecast till 2032
... Administration (Oral, Topical, Parenteral, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Europe, Asia-Pacific, and Rest of the World – Industry Forecast till 2032 In 2023, ... Read More
-
North America Generic Drugs Market Report and Forecast 2024-2032
... expected to grow at a CAGR of 6.80% during the forecast period of 2024-2032, driven by the expiration of patents on blockbuster drugs. The market is experiencing robust growth and is expected to reach USD ... Read More
-
United States Generic Drugs Market Report By Therapeutic Area (Epilepsy, Cancers, Heart Disease, Mental Health, Diabetes, Allergies & Asthama, Chronic Obstructive Pulmonary Diesase, Alzheimer's Disease, HIV/AIDS, Crohn's colitis), Type (Branded Generics, Unbranded Generics), Drug Delivery (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, Medicare D), States and Company analysis 2024-2032
... (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, ... Read More
-
North America Cold Sore Treatment (for HSV 1 Virus) Market
... growing at the CAGR of 7.2% in the forecast period of 2024 to 2031. Market Segmentation North America Cold Sore Treatment (for HSV 1 Virus) Market, By Treatment Type (Medications, Applied Products, Cold Sore Patches, ... Read More
Research Assistance
